SEC Form 4 · accession 0001209191-17-032231
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit Munshi
Officer — President and CEO · Director
Period of report
May 12, 2017
Accepted (ET)
May 15, 2017 · 8:04 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 12, 2017 | P | 25,000 | $1.19 | A | 76,875 | D |
Table II — derivative securities
No Table II lines on this filing.